Synergistic effects of intratumor administration of cis-diamminedichloroplatinum(II) combined with local hyperthermia in melanoma bearing mice

J Surg Oncol. 1992 Nov;51(3):188-94. doi: 10.1002/jso.2930510313.

Abstract

The synergistic effect of local hyperthermia (LHT) with intratumor injection (i.t.) of cis-diamminedichloroplatinum (II) (DDP) was studied using a rodent model with implanted B16 melanoma tumors. The hindfoot of the C57BL/6 mouse bearing the tumor was placed in a water bath at 42.5 +/- 0.2 degrees C (intratumor temperature was at 42.3 +/- 0.1 degrees C) for 30 minutes just after local (i.t.) or systemic (intraperitoneal;i.p.) administration of DDP (1-3 mg/kg once in experiment I and 1-3 mg/kg three times in experiment II). The tumor growth ratio (TGR) at 7 days after treatment in the group given DDP 3 mg/kg (i.t.) with LHT was 1.1 in experiment I and 0.5 in experiment II, and there was a statistically significant difference in both experiments compared to findings in other groups (P < 0.01). The mean survival time was 42.1 days in experiment I and 50.2 days in experiment II, with a significant difference in the latter (P < 0.001). Thus regional injection chemotherapy given concomitantly with local hyperthermia promotes the anticancer effects and improves the prognosis without either severe renal injury or the promotion of hematogenic metastasis.

MeSH terms

  • Animals
  • Body Weight
  • Cisplatin / analysis
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use*
  • Combined Modality Therapy
  • Hyperthermia, Induced*
  • Injections, Intralesional
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney Function Tests
  • Male
  • Melanoma, Experimental / therapy*
  • Mice
  • Mice, Inbred C57BL
  • Prognosis

Substances

  • Cisplatin